Cargando…

Adjuvant brachytherapy for FIGO stage I serous or clear cell endometrial cancer

OBJECTIVES: Optimal adjuvant treatment for early-stage clear cell and serous endometrial cancer remains unclear. We report outcomes for women with surgically staged International Federation of Gynecology and Obstetrics (FIGO) stage I clear cell, serous, and mixed endometrial cancers following adjuva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeans, Elizabeth B, Breen, William G, Mullikin, Trey C, Looker, Brittany A, Mariani, Andrea, Keeney, Gary L, Haddock, Michael G, Petersen, Ivy A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8223628/ https://www.ncbi.nlm.nih.gov/pubmed/33563642 http://dx.doi.org/10.1136/ijgc-2020-002217

Ejemplares similares

Survival of women with clear cell and papillary serous endometrial cancer after adjuvant radiotherapy
por: Foerster, Robert, et al.
Publicado: (2014)

FIGO staging of endometrial cancer: 2023
por: Berek, Jonathan S., et al.
Publicado: (2023)

Impact of the adjuvant management and risk factors on survival in FIGO stage 3 endometrial cancer patients
por: Tong, Nora, et al.
Publicado: (2023)

In search for biomarkers and potential drug targets for uterine serous endometrial cancer
por: Dinoi, Giorgia, et al.
Publicado: (2021)

Adjuvant vaginal cuff brachytherapy for high-risk, early stage endometrial cancer
por: Eldredge-Hindy, Harriet Belding, et al.
Publicado: (2014)

Outcomes of “sandwich” chemoradiotherapy compared with chemotherapy alone for the adjuvant treatment of FIGO stage III endometrial cancer
por: Wang, Shao-Jing, et al.
Publicado: (2022)

Preliminary results of modified interstitial MIAMI brachytherapy applicator for treatment of upper and apical vaginal tumors
por: Patel, Payal, et al.
Publicado: (2020)

The role of vaginal brachytherapy in stage I endometrial serous cancer: a systematic review
por: Lancellotta, Valentina, et al.
Publicado: (2020)

Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer
por: Donovan, Elysia, et al.
Publicado: (2018)

Impact of Adjuvant Chemotherapy on FIGO Stage I Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis
por: Yin, Min, et al.
Publicado: (2022)

A comparison of uterine papillary serous, clear cell carcinomas, and grade 3 endometrioid corpus cancers using 2009 FIGO staging system
por: Kim, Ha-Jeong, et al.
Publicado: (2013)

Brachytherapy for Central Serous Chorioretinopathy
por: Arora, Supriya, et al.
Publicado: (2022)

Adjuvant vaginal brachytherapy as a part of management in early endometrial cancer
por: Kellas-Ślęczka, Sylwia, et al.
Publicado: (2012)

Retrospective Analysis of Intravaginal Brachytherapy in Adjuvant Treatment of Early Endometrial Cancer
por: Cisek, Paweł, et al.
Publicado: (2018)

Mutational analysis of the tyrosine kinome in serous and clear cell endometrial cancer uncovers rare somatic mutations in TNK2 and DDR1
por: Rudd, Meghan L, et al.
Publicado: (2014)

Use of electronic brachytherapy to deliver postsurgical adjuvant radiation therapy for endometrial cancer: a retrospective multicenter study
por: Dooley, William C, et al.
Publicado: (2010)

Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
por: Kasius, Jenneke C., et al.
Publicado: (2021)

Stage I Clear Cell and Serous Uterine Carcinoma: What Is the Right Adjuvant Therapy?
por: Lefebvre, Manon, et al.
Publicado: (2023)

Critical Overview of Serous Endometrial Intraepithelial Cancer Treatment: Systematic Review of Adjuvant Options
por: Ronsini, Carlo, et al.
Publicado: (2023)

Adjuvant vaginal cuff brachytherapy in surgically treated endometrial carcinoma patients – in view of the recent evidence
por: Serkies, Krystyna, et al.
Publicado: (2021)

The percentage of peripheral eosinophils as a sensitive marker for differentiating FIGO grade in endometrial adenocarcinomas
por: Akış, Serkan, et al.
Publicado: (2022)

Molecular Classification of Endometrial Cancer and the 2023 FIGO Staging: Exploring the Challenges and Opportunities for Pathologists
por: Zheng, Wenxin
Publicado: (2023)

Metastatic serous endometrial carcinoma to the ureter
por: Sahl, Jessa W., et al.
Publicado: (2021)

Outcomes of Proton Beam Therapy Compared With Intensity-Modulated Radiation Therapy for Uterine Cancer
por: Anderson, Justin D., et al.
Publicado: (2022)

Adjuvant vaginal cuff brachytherapy: dosimetric comparison of conventional versus 3-dimensional planning in endometrial cancer
por: Gultekin, Melis, et al.
Publicado: (2020)

FIGO 2018 Staging for Cervical Cancer: Influence on Stage Distribution and Outcomes in the 3D-Image-Guided Brachytherapy Era
por: Tomizawa, Kento, et al.
Publicado: (2020)

Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
por: Ballester, Marcos, et al.
Publicado: (2010)

Uterine carcinosarcoma vs endometrial serous and clear cell carcinoma: A systematic review and meta‐analysis of survival
por: Raffone, Antonio, et al.
Publicado: (2021)

Gene Set-Based Functionome Analysis of Pathogenesis in Epithelial Ovarian Serous Carcinoma and the Molecular Features in Different FIGO Stages
por: Chang, Chia-Ming, et al.
Publicado: (2016)

Radical hysterectomy with adjuvant radiotherapy versus radical radiotherapy for FIGO stage IIB cervical cancer
por: Chai, Yanlan, et al.
Publicado: (2014)

Is adjuvant chemotherapy beneficial for patients with FIGO stage IC adult granulosa cell tumor of the ovary?
por: Wang, Dan, et al.
Publicado: (2018)

Chemoradiation with cisplatin followed by either brachytherapy or radical hysterectomy. A non-randomized comparison in FIGO stages IB2-IIA
por: Cetina, Lucely, et al.
Publicado: (2007)

Adjuvant brachytherapy for Stage IB Grade 2 endometrial carcinoma: Multivariate analysis of a single institution experience
por: Tokar, Margarita, et al.
Publicado: (2016)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

The FIGO Ovulatory Disorders Classification System
por: Munro, Malcolm G, et al.
Publicado: (2022)

The FIGO ovulatory disorders classification system
por: Munro, Malcolm G., et al.
Publicado: (2022)

Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
por: Huang, Chen-Yu, et al.
Publicado: (2020)

Development and Validation of Prognostic Nomogram for Primary Peritoneal Serous Carcinoma Compared With FIGO Staging System: A Population-Based Study
por: Chen, Ming, et al.
Publicado: (2021)

Changes in receipt of adjuvant brachytherapy for endometrial cancer patients before and after affordable care act: The impact of Medicaid expansion
por: Le, Amy, et al.
Publicado: (2023)

Global Work of the International Federation of Gynecology and Obstetrics (FIGO)
por: Serour, G.I.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ckd45qb1o1p399l193p0smpgls